ENYO Pharma Announces Two Vonafexor Data Presentations at AASLD
03 Nov 2021 //
BUSINESSWIRE
ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results
30 Jul 2021 //
BUSINESS WIRE
ENYO Pharma Announce +Ve Vonafexor Results for the LIVIFY Phase 2a Study
29 Jul 2021 //
BUSINESSWIRE
Enyo Pharma notches a mid-stage trial win in tricky NASH
28 Jul 2021 //
FIERCEBIOTECH